BISPECIFIC MOLECULE COMPRISING AN ANTI-CR1 ANTIBODY CROSS-LINKED TO AN ANTIGENBINDING ANTIBODY FRAGMENT

Details for Australian Patent Application No. 2003295330 (hide)

Owner ELUSYS THERAPEUTICS, INC.

Inventors Porter, James P.; Casey, Leslie; Wang, Xiaoliang; Sesay, Muctarr; Mohamed, Nehal; Lee, Lihsyng Stanford

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2003295330

PCT Number PCT/US2003/0290

PCT Pub. Number WO2004/032832

Priority 60/411,421 16.09.02 US

Filing date 16 September 2003

Wipo publication date 4 May 2004

Event Publications

22 April 2004 Complete Application Filed

  Priority application(s): 60/411,421 16.09.02 US

3 June 2004 Application Open to Public Inspection

  Published as AU-A-2003295330

9 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003295331-METHOD OF INDUCING MATURATION OF DENDRITIC CELLS AND USES THEREFOR

2003295329-FLUID EJECTION DEVICE AND METHOD OF MANUFACTURING A FLUID EJECTION DEVICE